RAN and hepatocellular carcinoma: Thus, in the present study, we determined whether polymorphisms in DICER (rs3742330 and rs13078), DROSHA (rs10719 and rs6877842), RAN (rs14035) and XPO5 (rs11077) were associated with HCC development and survival in a Korean population.